Filtered By:
Condition: Atrial Fibrillation
Procedure: Heart Valve Surgery

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 444 results found since Jan 2013.

Prognostic value of computer tomography derived measurements of pulmonary artery diameter on long term outcomes after transcatheter aortic valve replacement
CONCLUSION: PAD >29.3 mm in baseline MDCT is associated with higher 1-year mortality after TAVR, independently of echocardiographic measure of PH and frailty.PMID:35892248 | DOI:10.33963/KP.a2022.0173
Source: Kardiologia Polska - July 27, 2022 Category: Cardiology Authors: Łukasz Kalińczuk Zbigniew Chmielak Maciej D ąbrowski Marcin Mazurkiewicz Patrycjusz Stok łosa Wiktor Skotarczak Gary S Mintz Rafa ł Wolny Pawe ł Tyczyński Marek Konka Anna Micha łowska Ilona Kowalik Marcin Demkow Ilona Micha łowska Adam Witkowski Source Type: research

Comparison of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and an Aortic Bioprosthetic Valve
CONCLUSIONS: Among AF patients with an aortic BPV, no significant difference was observed in the composite outcome of adverse clinical events between patients treated with warfarin and those treated with DOACs, suggesting that DOACs can be used as alternatives to warfarin in these patients.PMID:35811134 | DOI:10.1253/circj.CJ-22-0226
Source: Circulation Journal - July 10, 2022 Category: Cardiology Authors: Makoto Miyake Misa Takegami Yuki Obayashi Masashi Amano Takeshi Kitai Tomoyuki Fujita Tadaaki Koyama Hidekazu Tanaka Kenji Ando Tatsuhiko Komiya Masaki Izumo Hiroya Kawai Kiyoyuki Eishi Kiyoshi Yoshida Takeshi Kimura Ryuzo Nawada Tomohiro Sakamoto Yoshisa Source Type: research

Silent Brain Infarction, Delirium, and Cognition in Three Invasive Cardiovascular Procedures: a Systematic Review
AbstractSilent brain infarctions (SBIs) are brain lesions noted on neuroimaging that are not associated with clinical symptoms. SBIs are associated with a number of vascular risk factors and are common following invasive cardiovascular procedures such as atrial fibrillation (AF) ablation, coronary artery bypass graft (CABG), and transcatheter aortic valve replacement (TAVR). Although not eliciting signs of clinical stroke, SBIs are associated with increased frailty, and motor and mood features. Less is known, however, about the relationship between SBI, cognition, and delirium following invasive cardiac procedures and most...
Source: Neuropsychology Review - July 8, 2022 Category: Neuroscience Source Type: research

The Impact of Aortic Root Enlargement on Patients undergoing Aortic Valve Replacement
CONCLUSIONS: ARE can be safely performed with isolated AVR and should be considered for patients with small annuli to avoid prosthesis-patient mismatch.PMID:35777500 | DOI:10.1016/j.athoracsur.2022.05.052
Source: The Annals of Thoracic Surgery - July 1, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Sarah Yousef James A Brown Derek Serna-Gallegos Forozan Navid Nav Warraich Pyongsoo Yoon David Kaczorowski Johannes Bonatti Yisi Wang Ibrahim Sultan Source Type: research

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news

Low serum albumin: A neglected predictor in patients with cardiovascular disease
Eur J Intern Med. 2022 May 7:S0953-6205(22)00181-9. doi: 10.1016/j.ejim.2022.05.004. Online ahead of print.ABSTRACTAlbumin, the most abundant circulating protein in blood, is an essential protein which binds and transports various drugs and substances, maintains the oncotic pressure of blood and influences the physiological function of the circulatory system. Albumin also has anti-inflammatory, antioxidant, and antithrombotic properties. Evidence supports albumin's role as a strong predictor of cardiovascular (CV) risk in several patient groups. Its protective role extends to those with coronary artery disease, heart failu...
Source: Atherosclerosis - May 10, 2022 Category: Cardiology Authors: Antonis A Manolis Theodora A Manolis Helen Melita Dimitri P Mikhailidis Antonis S Manolis Source Type: research

Comparison of the long-term outcomes and risk factors of aortic stenosis treatment - in patients undergoing transcatheter aortic valve implantation and surgical aortic valve replacement
CONCLUSIONS: There were no significant differences regarding prognosis after TAVI and SAVR at the 24-month follow-up in propensity score matching model. Independent predictive factors of late mortality after both procedures were EuroScore II and the respiratory failure. Independent predictive factors of late mortality specific for TAVI were NOAF, increased RDW and for SAVR: TIA, stroke, COPD and RBC transfusion.PMID:35521716 | DOI:10.33963/KP.a2022.0122
Source: Polish Heart Journal - May 6, 2022 Category: Cardiology Authors: Karolina Marzec Maria Jaworska-Wilczy ńska Ilona Kowalik Ma łgorzata Nieznańska Adam Witkowski Maciej D ąbrowski Krzysztof Ku śmierski Tomasz Hryniewiecki Source Type: research